The drugmaker saw a 150% increase in sales for its GLP-1s, now it thinks the worst of a supply chain glut may be over. Read More
The drugmaker saw a 150% increase in sales for its GLP-1s, now it thinks the worst of a supply chain glut may be over. Read More